Ian Peikon
Signal active
Co-Founder & Chief Scientific Officer
Bio
Ian is a molecular biologist, engineer, and entrepreneur. He has been involved in the formation and early company building of Lux portfolio companies including Kallyope as well as several other stealth Newcos.
Location
New York, New York, United States, North America
Social
Primary Organization
Cajal Neuroscience
Founded
2020
Employees
51-100
Industry
Biotechnology, Pharmaceutical, Therapeutics, Neuroscience
Jobs history
2
Cajal Neuroscience
Co-Founder & Chief Scientific Officer
2020 - Current
Lux Capital
Venture Partner
2019 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Ian Peikon is the Co-Founder & Chief Scientific Officer at Cajal Neuroscience, based in New York, New York, United States, North America. With a background in Biotechnology, Ian Peikon has a rich history of leadership and innovation. Ian Peikon studied BSE Biomedical Engineering @ Duke University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
2
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Jan 01, 2020 | Cajal Neuroscience | Seed Round - Cajal Neuroscience | Lux Capital | 0 |
| Nov 29, 2022 | Cajal Neuroscience | Series A - Cajal Neuroscience | Lux Capital | 96.0M |
Lux CapitalExits
0
There is no exit available on this Profile
Invest in industries
Recent Activity